Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RNA-targeted drugs for neuromuscular diseases

31 Dec 2020

Abstract excerpt

Progress with antisense oligonucleotide therapies opens a path for future development

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurogenetic and Muscular Disorders Research
Share to RNA Research and Splicing
Share to Viral Infections and Immunology Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33384365
DOI: 10.1126/science.aba4515

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RNA-targeted drugs for neuromuscular diseasesPMID 33384365Read ↗

Targeting RNA to treat neuromuscular diseaseSemantic proximity Read ↗

Emerging Oligonucleotide Therapeutics for Rare Neuromuscular DiseasesSemantic proximity Read ↗

Antisense Oligonucleotide-Based Therapy for Neuromuscular DiseaseSemantic proximity Read ↗

Clinical applications of exon-skipping antisense oligonucleotides in neuromuscular diseasesSemantic proximity Read ↗

Recent advances in antisense oligonucleotide therapy in genetic neuromuscular diseasesSemantic proximity Read ↗

Therapeutic antisense oligonucleotides for movement disordersSemantic proximity Read ↗

Antisense drugs for rare and ultra-rare genetic neurological diseasesSemantic proximity Read ↗

Antisense oligonucleotides: the next frontier for treatment of neurological disordersSemantic proximity Read ↗

Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseasesSemantic proximity Read ↗

Progress in therapeutic antisense applications for neuromuscular disorders.Semantic proximity Read ↗

Antisense oligonucleotides and their applications in rare neurological diseasesSemantic proximity Read ↗

Antisense oligonucleotides and other genetic therapies made simpleSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.